Why Cardlytics Stock Is Racing Higher After Earnings
Portfolio Pulse from Erica Kollmann
Cardlytics, Inc. (NASDAQ:CDLX) shares surged after reporting Q4 earnings of 14 cents per share, beating estimates of 12 cents, and issuing Q1 revenue guidance between $70 million and $73 million, surpassing the $66.46 million estimate. Despite a slight miss in Q4 sales, the company's year-over-year growth and positive outlook, supported by a Buy rating and raised price target from Needham analyst Kyle Peterson, have contributed to the stock's upward movement.
March 15, 2024 | 3:17 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Cardlytics reported higher-than-expected Q4 earnings and provided strong Q1 revenue guidance, leading to a stock price increase. The company's positive performance and outlook, along with an analyst upgrade, suggest potential for continued short-term growth.
Cardlytics' earnings beat and optimistic revenue guidance indicate strong company performance and potential for future growth. The analyst's upgrade further validates the positive outlook, likely influencing investor sentiment and stock price in the short term.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100